The Pink Sheet—

In this analysis piece, The Pink Sheet looks at the potential impact of the Trump Administration’s federal hiring freeze on the FDA – specifically, FDA positions supported by industry user fees . Catalyst President Nancy Bradish Myers provides her perspective, noting that there is no precedent for user fee positions in terms of a hiring freeze. She has also said FDA has a strong argument for an exemption from the hiring freeze due to its public health role, in addition to the user fee funding.

(Subscription required)